PT  - JOURNAL ARTICLE
ED  - Licata, Aneglo A.
AU  - Ciaccia, Angelina V.
AU  - Wong, Mayme
AU  - Draper, Michael W.
TI  - Raloxifene: A new choice for treating and preventing osteoporosis
DP  - 2000 Apr 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 273--280
VI  - 67
IP  - 4
4099  - http://www.ccjm.org/content/67/4/273.short
4100  - http://www.ccjm.org/content/67/4/273.full
SO  - Cleve Clin J Med2000 Apr 01; 67
AB  - Selective estrogen receptor modulators (SERMs) are a new class of drugs that provide a new option for addressing the health challenges of postmenopausal women. This review discusses the proposed mechanism of action of SERMs and describes clinical findings on raloxifene, a SERM now available for treating and preventing osteoporosis.